A phase I pharmacokinetic study of PM00104 (Zalypsis((R))) administered as a 24-h intravenous infusion every 3 weeks in patients with advanced solid tumors.
Saved in:
| Title: | A phase I pharmacokinetic study of PM00104 (Zalypsis((R))) administered as a 24-h intravenous infusion every 3 weeks in patients with advanced solid tumors. |
|---|---|
| Authors: | Capdevila, J (AUTHOR), Clive, S (AUTHOR), Casado, E (AUTHOR), Michie, C (AUTHOR), Piera, A (AUTHOR), Sicart, E (AUTHOR), Carreras, M J (AUTHOR), Coronado, C (AUTHOR), Kahatt, C (AUTHOR), Soto Matos-Pita, A (AUTHOR), Fernandez Teruel, C (AUTHOR), Siguero, M (AUTHOR), Cullell-Young, M (AUTHOR), Tabernero, J (AUTHOR) |
| Source: | Cancer Chemotherapy & Pharmacology. May2013, Vol. 71 Issue 5, p1247-1254. 8p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
